NDC properties for "Kyzatrex 150 MG Oral Capsule" (RxCUI 2609607)
About this data
The tables show NDC propoerties for Kyzatrex 150 MG Oral Capsule with the RxCUI 2609607
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Kyzatrex 150 MG Oral Capsule (RxCUI 2609607)
| MMSL_CODE | BD38854 |
|---|---|
| NDA | NDA213953 |
| RxCUI | 2609607 |
| SPL_SET_ID | 7f7167a7-2a25-47e2-acf5-33f499fce971 |
| Prescribable Synonym | KYZATREX 150 MG Oral Capsule |
| RXNAV_STR | Kyzatrex 150 MG Oral Capsule |
| RxNorm Name | testosterone undecanoate 150 MG Oral Capsule [Kyzatrex] |
| RxNorm Synonym | Kyzatrex 150 MG Oral Capsule |
| Related queries | Interactions (for RxCUI 2609607) |
NDC Properties
NDC Item 80603010311
| NDC 9 | 80603-103 |
|---|---|
| NDC 10 | 80603-103-11 |
| NDC Item | 80603010311 |
| Packaging | 90 CAPSULE, LIQUID FILLED in 1 BOTTLE (80603-103-11) |
| COLORTEXT | white(opaque) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 740043 |
| Imprint code | MP150 |
| Labeler | Marius Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-07-27 |
| Marketing status | ACTIVE |
| NDA | NDA213953 |
| Score | 1 |
| Shapetext | Oblong |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 80603-103 |
NDC Item 80603010322
| NDC 9 | 80603-103 |
|---|---|
| NDC 10 | 80603-103-22 |
| NDC Item | 80603010322 |
| Packaging | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (80603-103-22) |
| COLORTEXT | white(opaque) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 740043 |
| Imprint code | MP150 |
| Labeler | Marius Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-07-27 |
| Marketing status | ACTIVE |
| NDA | NDA213953 |
| Score | 1 |
| Shapetext | Oblong |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 80603-103 |
NDC Item 80603010311
| NDC 9 | 80603-103 |
|---|---|
| NDC 10 | 80603-103-11 |
| NDC Item | 80603010311 |
| Packaging | 90 CAPSULE, LIQUID FILLED in 1 BOTTLE (80603-103-11) |
| COLORTEXT | white(opaque) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 740043 |
| Imprint code | MP150 |
| Labeler | Marius Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-07-27 |
| Marketing status | ACTIVE |
| NDA | NDA213953 |
| Score | 1 |
| Shapetext | Oblong |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 80603-103 |
NDC Item 80603010322
| NDC 9 | 80603-103 |
|---|---|
| NDC 10 | 80603-103-22 |
| NDC Item | 80603010322 |
| Packaging | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (80603-103-22) |
| COLORTEXT | white(opaque) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 740043 |
| Imprint code | MP150 |
| Labeler | Marius Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-07-27 |
| Marketing status | ACTIVE |
| NDA | NDA213953 |
| Score | 1 |
| Shapetext | Oblong |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 80603-103 |